In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
 Peter R Sinnaeve
Speaker
Peter R Sinnaeve
Peter R Sinnaeve Peter R Sinnaeve

University Hospitals (UZ) Leuven, Leuven (Belgium)

Specialities : Acute Coronary Syndromes , Basic Science, Interventional Cardiology, Pericardial Disease, Rehabilitation and Sports Cardiology

Peter R Sinnaeve (°1969) graduated summa cum laude from the University of Leuven in 1994, and trained as a cardiologist at the same institution. He subsequently obtained a PhD degree and did a post-doctoral fellowship at the Duke Clinical Research Institute in the USA. Dr Sinnaeve then joined the staff at University Hospitals, Leuven, Belgium. He is currently professor at the University of Leuven, and is a Clinical Investigator for the Fund for Scientific Research Flanders. His clinical expertise lies in acute cardiac care, interventional cardiology, pericardiology, as well as cardiac rehabilitation, while his current research focuses on antithrombotic therapies and the genomics of acute coronary syndromes. He is active in a variety of national and international boards.

8 presentations from this speaker

Management of atrial fibrillation patients with concomitant need for antiplatelet therapy: Is the dilemma resolved?

Event : ESC Congress 2019

  • Session : Improving outcomes with non-vitamin K antagonist oral anticoagulants (NOACs): Focus on atrial fibrillation patients with acute coronary syndrome (ACS) and/or undergoing percutaneous coronary intervention (PCI)
  • Speaker : PR Sinnaeve (Leuven,BE)
  • Sponsored by The Bristol-Myers Squibb/Pfizer Alliance

New insights into risk assessment and prevention in STEMI patients

Event : ESC Congress 2019

  • Session : STEMI care today: can we do better?
  • Speaker : PR Sinnaeve (Leuven,BE)
  • Sponsored by Boehringer Ingelheim

Networks and reperfusion strategies for STEMI and ischaemic stroke: interactive discussion session.

Event : ESC Congress 2017

  • Session : Challenges and opportunities of establishing reperfusion networks for ST-segment elevation myocardial infarction (STEMI) and for acute stroke
  • Speaker : P Goldstein (Lille Cedex,FR), R Welsh (Edmonton,CA), C Molina (Barcelona,ES), PR Sinnaeve (Leuven,BE), D Leys (Lille,FR), PW Armstrong (Alberta,CA), F Van de Werf (Leuven,BE)
  • Sponsored by Boehringer Ingelheim International GmbH

New evidence that emerged since the guidelines were published.

Event : ESC Congress 2017

  • Session : NSTE-ACS
  • Speaker : PR Sinnaeve (Leuven,BE)

Case 2. ACS/PCI: patient cases based on real world data.

Event : ESC Congress 2014

  • Session : ACS management 2014: a case based approach according to new guidelines and registries
  • Speaker : PR Sinnaeve (Leuven,BE)
  • Organised by Leiden University Medical Centre / Course Director: Wouter Jukema / Supported by an unrestricted educational grant from Physicians’ Academy for Cardiovascular Education

New registries on ACS/PCI: how does the real world look like.

Event : ESC Congress 2014

  • Session : ACS management 2014: a case based approach according to new guidelines and registries
  • Speaker : PR Sinnaeve (Leuven,BE)
  • Organised by Leiden University Medical Centre / Course Director: Wouter Jukema / Supported by an unrestricted educational grant from Physicians’ Academy for Cardiovascular Education

Leptin-adiponectin ratio and the extent of CAD in pre-diabetic patients undergoing PCI

Event : ESC Congress 2013

  • Session : Obesity: lowering risk
  • Speaker : PR Sinnaeve (Leuven,BE)

Members get more

Join now
  • 1ESC Professional Members – access all resources from general ESC events 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are